BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35606020)

  • 1. Improved glucometrics in people with type 1 diabetes 1 year into the COVID-19 pandemic.
    Ali N; El Hamdaoui S; Nefs G; Tack CJ; De Galan BE
    BMJ Open Diabetes Res Care; 2022 May; 10(3):. PubMed ID: 35606020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic.
    Ruissen MM; Regeer H; Landstra CP; Schroijen M; Jazet I; Nijhoff MF; Pijl H; Ballieux BEPB; Dekkers O; Huisman SD; de Koning EJP
    BMJ Open Diabetes Res Care; 2021 Jan; 9(1):. PubMed ID: 33431602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved CGM Glucometrics and More Visits for Pediatric Type 1 Diabetes Using Telemedicine During 1 Year of COVID-19.
    Kaushal T; Tinsley LJ; Volkening LK; Turcotte C; Laffel LM
    J Clin Endocrinol Metab; 2022 Sep; 107(10):e4197-e4202. PubMed ID: 35948357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial.
    Wada E; Onoue T; Kobayashi T; Handa T; Hayase A; Ito M; Furukawa M; Okuji T; Okada N; Iwama S; Sugiyama M; Tsunekawa T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Kuwatsuka Y; Ando M; Goto M; Arima H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32518063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6).
    Lameijer A; Fokkert MJ; Edens MA; Gans ROB; Bilo HJG; van Dijk PR
    BMJ Open Diabetes Res Care; 2021 Sep; 9(1):. PubMed ID: 34521652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies.
    Garofolo M; Aragona M; Rodia C; Falcetta P; Bertolotto A; Campi F; Del Prato S; Penno G
    Diabetes Res Clin Pract; 2021 Oct; 180():109066. PubMed ID: 34563586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic.
    Swaich H; Advani A
    Diabetes Ther; 2023 Jan; 14(1):153-165. PubMed ID: 36467396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stay-at-Home Orders During the COVID-19 Pandemic, an Opportunity to Improve Glucose Control Through Behavioral Changes in Type 1 Diabetes.
    Potier L; Hansel B; Larger E; Gautier JF; Carreira D; Assemien R; Lantieri O; Riveline JP; Roussel R
    Diabetes Care; 2021 Mar; 44(3):839-843. PubMed ID: 33361146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of socioeconomic status on chronic control and complications of type 1 diabetes mellitus in users of glucose flash systems: a follow-up study.
    Sebastian-Valles F; Martínez-Alfonso J; Arranz Martin JA; Jiménez-Díaz J; Hernando Alday I; Navas-Moreno V; Joya TA; Fandiño García MDM; Román Gómez GL; Garai Hierro J; Lander Lobariñas LE; Martínez de Icaya P; Sampedro-Nuñez MA; Martínez-Vizcaíno V; Marazuela M
    BMC Med; 2024 Jan; 22(1):37. PubMed ID: 38273326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of flash glucose monitoring on glycemic control varies with the age and residual β-cell function of patients with type 1 diabetes mellitus.
    Zhang L; Xu Y; Jiang X; Wu J; Liu F; Fan L; Li X; Yin G; Yang L
    J Diabetes Investig; 2022 Mar; 13(3):552-559. PubMed ID: 34637185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes.
    Caruso I; Di Molfetta S; Guarini F; Giordano F; Cignarelli A; Natalicchio A; Perrini S; Leonardini A; Giorgino F; Laviola L
    Diabetes Metab Res Rev; 2021 Sep; 37(6):e3404. PubMed ID: 32918324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pragmatic real-life study of flash glucose monitoring versus self-monitoring of blood glucose.
    Greve SV; Stilgren L
    Dan Med J; 2020 Jun; 67(6):. PubMed ID: 32741434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved seasonal variation in glycemic control in patients with type 2 diabetes mellitus during COVID-19: a 3-year-long retrospective cohort study in older adults in Japan.
    Iwata S; Ashida K; Demiya M; Nagayama A; Hasuzawa N; Yoshinobu S; Sonezaki A; Yasuda J; Motomura S; Katsuki Y; Sugi K; Nomura M
    BMC Endocr Disord; 2024 May; 24(1):70. PubMed ID: 38755559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes.
    Stimson RH; Dover AR; Ritchie SA; Wright RJ; McKnight JA; Zammitt NN; Gibb FW
    BMJ Open Diabetes Res Care; 2020 Jul; 8(1):. PubMed ID: 32719078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of telemedicine on glycemic control in type 2 diabetes mellitus during the COVID-19 lockdown period.
    Al-Mutairi AM; Alshabeeb MA; Abohelaika S; Alomar FA; Bidasee KR
    Front Endocrinol (Lausanne); 2023; 14():1068018. PubMed ID: 36817609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis.
    Castellana M; Parisi C; Di Molfetta S; Di Gioia L; Natalicchio A; Perrini S; Cignarelli A; Laviola L; Giorgino F
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32487593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies.
    Silverii GA; Delli Poggi C; Dicembrini I; Monami M; Mannucci E
    Acta Diabetol; 2021 Dec; 58(12):1603-1611. PubMed ID: 34159476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scans per day as predictors of optimal glycemic control in people with type 1 diabetes mellitus using flash glucose monitoring: what number of scans per day should raise a red flag?
    Sebastian-Valles F; Martínez-Alfonso J; Arranz Martin JA; Jiménez-Díaz J; Hernando Alday I; Navas-Moreno V; Armenta Joya T; Fandiño García MDM; Román Gómez GL; Lander Lobariñas LE; Martinez de Icaya P; Sampedro-Nuñez MA; Martínez-Vizacaíno V; Marazuela M
    Acta Diabetol; 2024 Mar; 61(3):343-350. PubMed ID: 37930420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.